Eli Lilly and Co - Company Profile
Powered by 
All the data and insights you need on Eli Lilly and Co in one report.
$295
- Save hours of research time and resources with
our up-to-date Eli Lilly and Co Strategy Report
- Understand Eli Lilly and Co position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Business Description
Eli Lilly and Co (Lilly) discovers, develops, manufactures, and markets products related to various therapeutic areas including cancer, cardiology, diabetes, men's health, neurological problems, endocrine disorders, and others. The company operates in a single segment: Human Pharmaceutical Products. It classifies its products into five categories, namely, Diabetes, Immunology, Neuroscience, Oncology and Others.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
Through its R&D efforts, Lilly strives to develop new products and improve existing products. Lilly’s human pharmaceutical research focuses essentially on the areas of diabetes, obesity, cancer, neurodegeneration, immune disorders, and pain. The major pipeline products of the company in Phase III trials include Orforglipron, Retatrutide, Empagliflozin, Insulin Efsitora Alfa, and Tirzepatide for diabetes; and Mirikizumab for immune disorders. The Neuroscience pipeline includes Donanemab, and Remternetug in Phase III trials. The Oncology pipeline consists of Selpercatinib, Pirtobrutinib, Abemaciclib and Imlunestrant. In FY2023, the company spent US$9,313.4 million on R&D, which as a percentage of its revenue, stood at 27.3%. As of December 31, 2023, it employed 10,000 personnel in R&D. The company owns numerous US and foreign patents related to products, product uses, formulations, and manufacturing processes. Lilly has collaborations with academic institutions and research-based pharmaceutical and biotechnology companies.
Product Categories
Overview
Offers products for the treatment of various types of diabetes. Major products include: Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, and insulin lispro mix 75/25, Humulin, Mounjaro, Jardiance, Zepbound, and Trulicity.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Provides products for the treatment of atopic dermatitis, severe alopecia areataulcerative colitis, plaque psoriasis, and other immunological disorders. Major products include: Olumiant, Ebglyss, Omvoh, and Taltz.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Offers products for major depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, chronic musculoskeletal pain, migraine, and episodic cluster headache. Major products include Cymbalta and Emgality.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Offers products for the treatment of non-small cell lung cancer (NSCLC), colorectal cancers, mantle cell lymphoma (MCL), and breast cancer. Major products include: Alimta, Cyramza, Erbitux, Retevmo, Tyvyt, Verzenio, and Jaypirca.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Includes products for the treatment of erectile dysfunction and benign prostatic hyperplasia. Major products include Cialis and Forteo.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Geographical Segments
Capital Expenditure
Reported revenue of US$1,539.7 million for FY2023, which grew 6.0% YoY, and recorded negative growth of 3.7% during 2021-23. China accounted for 4.5% of the company's revenue in FY2023.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer